Is effective and safe a radiochemotherapy approach in elderly cancer patients? A review

Francesco Fiorica, Antonio Zanghì, Giuliana Pascale, Otilia Nuta, Lino Del Pup, Antonio Stefanelli, Francesco Cartei

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Although more than 60% of all cancer patients in Europe and the USA are older than 65 years at the time of diagnosis, elderly patients are generally under-represented in clinical trials. A general consensus on how to treat elderly patients is still far from being achieved. In this review, we address some of the issues and challenges surrounding the treatment of older cancer patients and radiochemotherapy. We discuss the existing evidence related to radiochemotherapy in the elderly, focusing primarily on the malignancies most commonly seen in older patients and making general treatment recommendations where applicable.

Original languageEnglish
Pages (from-to)1430-1437
Number of pages8
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume13
Issue number9
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Chemoradiotherapy
Neoplasms
Clinical Trials
Therapeutics

Keywords

  • Clinical trials
  • Elderly patients
  • Geriatric oncology
  • Radiochemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Pharmacology
  • Medicine(all)

Cite this

Is effective and safe a radiochemotherapy approach in elderly cancer patients? A review. / Fiorica, Francesco; Zanghì, Antonio; Pascale, Giuliana; Nuta, Otilia; Del Pup, Lino; Stefanelli, Antonio; Cartei, Francesco.

In: Anti-Cancer Agents in Medicinal Chemistry, Vol. 13, No. 9, 2013, p. 1430-1437.

Research output: Contribution to journalArticle

Fiorica, Francesco ; Zanghì, Antonio ; Pascale, Giuliana ; Nuta, Otilia ; Del Pup, Lino ; Stefanelli, Antonio ; Cartei, Francesco. / Is effective and safe a radiochemotherapy approach in elderly cancer patients? A review. In: Anti-Cancer Agents in Medicinal Chemistry. 2013 ; Vol. 13, No. 9. pp. 1430-1437.
@article{f4afd0b95a084f6499b9c406115ec001,
title = "Is effective and safe a radiochemotherapy approach in elderly cancer patients? A review",
abstract = "Although more than 60{\%} of all cancer patients in Europe and the USA are older than 65 years at the time of diagnosis, elderly patients are generally under-represented in clinical trials. A general consensus on how to treat elderly patients is still far from being achieved. In this review, we address some of the issues and challenges surrounding the treatment of older cancer patients and radiochemotherapy. We discuss the existing evidence related to radiochemotherapy in the elderly, focusing primarily on the malignancies most commonly seen in older patients and making general treatment recommendations where applicable.",
keywords = "Clinical trials, Elderly patients, Geriatric oncology, Radiochemotherapy",
author = "Francesco Fiorica and Antonio Zangh{\`i} and Giuliana Pascale and Otilia Nuta and {Del Pup}, Lino and Antonio Stefanelli and Francesco Cartei",
year = "2013",
doi = "10.2174/18715206113136660354",
language = "English",
volume = "13",
pages = "1430--1437",
journal = "Anti-Cancer Agents in Medicinal Chemistry",
issn = "1871-5206",
publisher = "Bentham Science Publishers",
number = "9",

}

TY - JOUR

T1 - Is effective and safe a radiochemotherapy approach in elderly cancer patients? A review

AU - Fiorica, Francesco

AU - Zanghì, Antonio

AU - Pascale, Giuliana

AU - Nuta, Otilia

AU - Del Pup, Lino

AU - Stefanelli, Antonio

AU - Cartei, Francesco

PY - 2013

Y1 - 2013

N2 - Although more than 60% of all cancer patients in Europe and the USA are older than 65 years at the time of diagnosis, elderly patients are generally under-represented in clinical trials. A general consensus on how to treat elderly patients is still far from being achieved. In this review, we address some of the issues and challenges surrounding the treatment of older cancer patients and radiochemotherapy. We discuss the existing evidence related to radiochemotherapy in the elderly, focusing primarily on the malignancies most commonly seen in older patients and making general treatment recommendations where applicable.

AB - Although more than 60% of all cancer patients in Europe and the USA are older than 65 years at the time of diagnosis, elderly patients are generally under-represented in clinical trials. A general consensus on how to treat elderly patients is still far from being achieved. In this review, we address some of the issues and challenges surrounding the treatment of older cancer patients and radiochemotherapy. We discuss the existing evidence related to radiochemotherapy in the elderly, focusing primarily on the malignancies most commonly seen in older patients and making general treatment recommendations where applicable.

KW - Clinical trials

KW - Elderly patients

KW - Geriatric oncology

KW - Radiochemotherapy

UR - http://www.scopus.com/inward/record.url?scp=84888262994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888262994&partnerID=8YFLogxK

U2 - 10.2174/18715206113136660354

DO - 10.2174/18715206113136660354

M3 - Article

VL - 13

SP - 1430

EP - 1437

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

SN - 1871-5206

IS - 9

ER -